Standard Biotools earnings were -$132.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LAB earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$26.0M, down 23.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LAB reported annual earnings of -$184.9M, with 147.7% growth. The next LAB earnings date is Jul 29, 2025.
What were Standard Biotools's earnings last quarter?
On LAB's earnings call on Invalid Date, Standard Biotools (NASDAQ: LAB) reported Q1 2025 earnings per share (EPS) of -$0.07, up 74.07% year over year. Total LAB earnings for the quarter were -$26.03 million. In the same quarter last year, Standard Biotools's earnings per share (EPS) was -$0.27.
The next LAB earnings call is Invalid Date. Add LAB to your watchlist to be reminded of Standard Biotools's next earnings date.
What was LAB's earnings growth in the past year?
As of Standard Biotools's earnings date in Invalid Date, Standard Biotools's earnings has grown year over year. LAB earnings in the past year totalled -$132.76 million.
Is Standard Biotools profitable or losing money?
As of the last Standard Biotools earnings report, Standard Biotools is currently losing money. Standard Biotools's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$132.76 million, a 47.56% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.